Skip to main content

BioRestorative Therapies, Inc.

BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001505497

No open-market purchases or sales by BioRestorative Therapies, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.00M in total; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +9 vs. previous quarter
23
13F valueReported value at the end of Q2 2026
$1.00M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding BRTX, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding BRTX at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by BioRestorative Therapies, Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 5, 2024 (view filing)Oct 288 daysLateBroadrick Dale10% OwnerSSale−1.11K$1.58−$1.76K−0.2%445.9K after
Apr 10, 2024 (view filing)Apr 8-92 daysSilva FranciscoVP of Research and DevelopmentPPurchase+8.31K$1.23+$10.2K+5.6%155.8K after3 lots
Feb 12, 2024 (view filing)Feb 8-94 daysBroadrick Dale10% OwnerPPurchase+160.0K$1.29+$206.0K+50.3%478.0K after2 lots
Feb 9, 2024 (view filing)Feb 7-82 daysBroadrick Dale10% OwnerPPurchase+120.0K$1.35+$162.3K+36.7%447.0K after2 lots
Dec 5, 2023 (view filing)Dec 14 daysBroadrick Dale10% OwnerSSale−250$1.88−$470−0.1%327.0K after
Dec 1, 2023 (view filing)Nov 274 daysLateBroadrick Dale10% OwnerSSale−278$1.89−$525.42−0.1%327.3K after
Sep 18, 2023 (view filing)Sep 14-154 daysBroadrick Dale10% OwnerPPurchase+20.0K$1.60+$32.0K+6.5%327.6K after2 lots
Sep 18, 2023 (view filing)Sep 153 daysAlstodt LancePresident, CEO, COBPPurchase+2.20K$1.70+$3.74K+1.2%189.5K after
Sep 14, 2023 (view filing)Jul 28-Sep 748 daysLateBroadrick Dale10% OwnerPPurchase+1.50K$2.17+$3.25K+0.5%307.6K after2 lots
Sep 14, 2023 (view filing)Sep 77 daysLateBroadrick Dale10% OwnerPPurchase+1.00K$1.91+$1.91K+0.3%318.0K after

Top 10 13F holders, Q2 2026

The largest institutional positions in BioRestorative Therapies, Inc. at the end of Q2 2026; share changes are against Q1 2026.

See all 23 holders
Institutions holding BRTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jane Street Group, LLC803,513$302.1K0.00%+803,513New
HRT Financial LP710,590$267.0K0.00%+710,590New
XTX Topco Ltd286,504$107.7K0.00%+286,504New
Citadel Advisors LLC273,304$102.8K0.00%+34,698+14.5%Added
Vanguard Fiduciary Trust Co181,300$68.2K0.00%+141,848+359.5%Added
Geode Capital Management, LLC152,417$57.3K0.00%−70,666−31.7%Reduced
Citigroup Inc63,724$24.0K0.00%+63,724New
Wealth Alliance40,000$15.0K0.00%00.0%Unchanged
State Street Corp32,459$12.2K0.00%00.0%Unchanged
Keystone Financial Group28,600$10.8K0.00%+28,600New